An antibody is a protein (natural substance) made by the body that works as a defense system against disease.
An antibody-drug conjugate (ADC) is a manufactured drug containing an antibody attached to an active anti-cancer agent. The ADC attaches to and enters targeted cells and kills them without harming other cells in the body.
A B cell is a type of white blood cell (part of the immune system) that makes antibodies to fight bacteria and viruses.
Chemoimmunotherapy is a type of treatment regimen that combines chemotherapy and immunotherapy.
Chemotherapy is a type of medicine that kills cells that grow and divide rapidly, including both cancer cells and normal cells.
A cycle is the time between one round of treatment until the start of the next.
Diffuse large B-cell lymphoma, or DLBCL, is a type of aggressive blood cancer that affects B cells. It is the most common form of non-Hodgkin’s lymphoma. DLBCL, not otherwise specified (NOS) refers to a form of DLBCL that cannot be categorized into a more specific subtype.
Immunotherapy is a type of targeted treatment that helps your immune system recognize and fight cancer. It may also affect healthy cells.
Non-Hodgkin’s lymphoma is a diverse group of blood cancers that affect different types of white blood cells. B cells are the most common type, and the most common subtype is DLBCL.
R-CHOP is an acronym for the following medicines: a rituximab product (R); cyclophosphamide (C); doxorubicin, also known as Adriamycin (H); vincristine, also known as Oncovin (O); and prednisone (P). R-CHOP is the traditional chemoimmunotherapy regimen that has been historically used in the treatment of newly diagnosed DLBCL.
R-CHP (pronounced “AR-chip”) is an acronym that represents the following medicines: a rituximab product (R); cyclophosphamide (C); doxorubicin, also known as Adriamycin (H); and prednisone (P). In addition to POLIVY, R-CHP also helps fight cancer.
Remission is the reduction in (partial) or disappearance of (complete) signs and symptoms of cancer in response to treatment.
The information contained in this section of the site is intended for US healthcare professionals only. Click "OK" if you are a healthcare professional.
The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.